Exploring inhibition of chemiluminescence mechanisms with fluorescence quenching studies and interaction energy calculations
Exploring inhibition of chemiluminescence mechanisms with fluorescence quenching studies and interaction energy calculations
Carbamates weaken the luminol-H2 O2 chemiluminescence (CL) catalyzed by sodium copper chlorophyll(SCC). The capacity to inhibit the CL of three carbamates is in the order of carbaryl (CBL) >carbofuran (CBF)>metolcarb (MTC). Mechanisms of carbamates inhibiting SCC-luminol-H2 O2 CL are investigated using fluorescencequenching and quantum chemistry simulations for the first time in this work. Carbamate-SCC interactions studiedusing fluorescence spectroscopy show that with the increasing concentration of the SCC, the fluorescence of carbamateis quenched regularly, and the quenching mechanism is a static quenching process. Binding constants (KB) of the threecarbamates with SCC are CBL (4.39 × 10 5) >CBF (1.46 × 10 4) >MTC (2.16 × 10 3 L/mol), which is completelyharmonious with the capacity to inhibit CL of the carbamates. Furthermore, the carbamate-SCC interaction energiesfrom quantum chemistry simulations are CBL-porphyrin copper (PPCu) (–30.1), CBF-PPCu (–21.0), and MTC-PPCu(–19.9 kJ/mol), which is also identical to their inhibiting capacity. This provides further evidence that the formation ofcarbamate-SCC complexes reduces the SCC catalytic activity and the CL intensity decreases. In addition, a novel flowinjection chemiluminescence method for the determination of carbamate was established based on carbamate inhibitingCL of the SCC-luminol-H2 O2 CL system under alkaline conditions. This work may contribute to the study of themechanism of CL inhibition using fluorescence quenching and quantum chemistry calculation methods.
___
- 1. Cui, H.; Meng, R.; Jiang, H.; Sun, Y.; Lin, X. Luminescence 1999, 14, 175-182.
- 2. Whitehead, T. P.; Thorpe, G. H. G.; Maxwell, S. R. J. Anal. Chim. Acta 1992, 266, 265-277.
- 3. MacDonald, A.; Nieman, T. A. Anal. Chem. 1985, 57, 936-940.
- 4. Koerner, P. J.; Nieman, T. A. Microchim. Acta 1987, 92, 79-90.
- 5. Han, S.; Liu, E.; Li, H. Luminescence 2006, 21, 106-111.
- 6. Petropoulou, S. S. E.; Gikas, E.; Tsarbopoulos, A.; Siskos, P. A. J. Chromatogr. A 2006, 1108, 99-110.
- 7. Aprea, C.; Colosio, C.; Mammone, T.; Minoia, C.; Maroni, M. J. Chromatogr. B 2002, 769, 191-219.
- 8. Forman, S.; Novák, J.; Tykva, R.; Kás, J.; Wimmer, Z.; Ruml, T. Chemosphere 2002, 46, 209-217.
- 9. Fernández, J. M.; Vázquez, P. P.; Vidal, J. L. M. Anal. Chim. Acta 2000, 412, 131-139.
- 10. Bolognesi, C. Mutat. Res. 2003, 543, 251-272.
- 11. Knaak, J. B.; Yee, K.; Ackerman, C. R.; Zweig, G.; Fry, D. M.; Wilson, B. W. Toxicol. Appl. Pharmacol. 1984, 76, 252-263.
- 12. López-Paz, J. L.; Catalá-Icardo, M. Anal. Lett. 2011, 44, 146-175.
- 13. Bordbar, A. K.; Taheri-Kafrani, A. Colloid. Surface. B 2007, 55, 84-89.
- 14. Cui, F.; Zhang, Q.; Yao, X.; Luo, H.; Yang, Y.; Qin, L.; Qu, G.; Lu, Y. Pestic. Biochem. Physiol. 2008, 90, 126-134.
- 15. Cui, F.; Qin, L.; Zhang, G.; Liu, Q.; Yao, X.; Lei, B. J. Pharm. Biomed. Anal. 2008, 48, 1029-1036.
- 16. Hu, Y. J.; Liu, Y.; Pi, Z. B.; Qu, S. S. Bioorg. Med. Chem. 2005, 13, 6609-6614.
- 17. van de Weert, M.; Stella, L. J. Mol. Struct. 2011, 998, 144-150.
- 18. Zierkiewicz, W.; Fanfrlík, J.; Hobza, P.; Michalska, D.; Zeegers-Huyskens, T. Theor. Chem. Acc. 2016, 135, 1-11.
- 19. Wei, Q.; Li, Q.; Cheng, J.; Li, W.; Li, H.-B. RSC Adv. 2016, 6, 79245-79253.
- 20. Paul, D. B. Talanta 1978, 25, 377-382.
- 21. Feng, X. Z.; Lin, Z.; Yang, L. J.; Wang, C.; Bai, C. L. Talanta 1998, 47, 1223-1229.
- 22. Kandagal, P. B.; Ashoka, S.; Seetharamappa, J.; Shaikh, S. M. T.; Jadegoud, Y.; Ijare, O. B. J. Pharm. Biomed. Anal. 2006, 41, 393-399.
- 23. Guo, Y.; Yue, Q.; Gao, B. Environ. Toxicol. Pharmacol. 2010, 30, 45-51.
- 24. Boys, S. F.; Bernardi, F. Mol. Phys. 1970, 19, 553-566.
- 25. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A. et al. Gaussian 09, Revision. A.02; Gaussian, Inc.: Wallingford, CT, USA, 2009.